fnms2020apple
Lv7
4040 积分
2020-08-26 加入
-
Systematic review and model-based analysis to identify whether renal safety risks of URAT1 inhibitors are fully determined by uric acid-lowering efficacies
8天前
已完结
-
Overview of the pharmacokinetics and pharmacodynamics of URAT1 inhibitors for the treatment of hyperuricemia and gout
8天前
已完结
-
Virtual screening and biological evaluation of natural products as urate transporter 1 (URAT1) inhibitors
8天前
已完结
-
Combination Treatment with Verinurad and Allopurinol in CKD: A Randomized Placebo and Active Controlled Trial
8天前
已关闭
-
Evaluation of Pharmacokinetic Interactions Between Lesinurad, a New Selective Urate Reabsorption Inhibitor, and Commonly Used Drugs for Gout Treatment
11天前
已完结
-
A Drug–Drug Interaction Study of a Novel Selective Urate Reabsorption Inhibitor, SHR4640, and Xanthine Oxidase Inhibitor, Febuxostat, in Patients With Primary Hyperuricemia
11天前
已完结
-
A Phase I Study to Evaluate the Pharmacokinetic Drug‒Drug Interaction of HP501, Febuxostat, and Colchicine in Male Chinese Patients with Hyperuricemia
11天前
已完结
-
A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis
26天前
已完结
-
The impact of canagliflozin on the risk of neuropathy events
1个月前
已完结
-
A Drug–Drug Interaction Study of a Novel Selective Urate Reabsorption Inhibitor, SHR4640, and Xanthine Oxidase Inhibitor, Febuxostat, in Patients With Primary Hyperuricemia
4个月前
已完结